若您需要咨询产品或有任何技术问题,请通过官方电话 400 885 9050 或邮箱 info.cn@stemcell.com 与我们联系。

TeSR™-E8™

无饲养层、无动物成分的人胚胎干细胞和诱导多能干细胞维持培养基
只有 %1
¥2,774.00

产品号 #(选择产品)

产品号 #05990_C

无饲养层、无动物成分的人胚胎干细胞和诱导多能干细胞维持培养基

产品优势

  • 基于广受欢迎的 mTeSR™1 培养基的简化低蛋白配方,用于维持培养人胚胎干细胞(ESCs)和诱导多能干细胞(iPSCs)

产品组分包括

  • TeSR™-E8™ 基础培养基,480 mL
  • TeSR™-E8™ 25X 补充剂,20 mL

总览

TeSR™-E8™ 是一款无饲养层、无动物成分的培养基,适用于培养人胚胎干细胞 (ES) 和人诱导性多能干细胞 (iPS)。它基于威斯康星大学麦迪逊分校 James Thomson 博士实验室研发的 E8 配方,该实验室是 mTeSR™1 研发的主导研发团队,mTeSR™1 是目前发表论文中使用最广泛的多能干细胞无饲养层培养基。

与 TeSR™ 产品家族中的其他产品一样,TeSR™-E8™ 培养基以最高标准和严谨工艺生产。该培养基专门研发,仅包含维持 ESCs 和 iPSCs 生长所需的必需成分,是多能干细胞培养中最简化的培养基。TeSR™-E8™ 可搭配 Corning® Matrigel® hESC-Qualified Matrix(Corning 354277)一起使用,若需完全明确的无异源成分系统,可选用 Vitronectin XF™(产品号 #07180)或 Laminin-521(产品号 #77003)作为培养基质。

 

分类
专用培养基
 
细胞类型
多能干细胞
 
种属

 
应用
细胞培养,扩增,培养
 
品牌
TeSR
 
研究领域
干细胞生物学
 
制剂类别
无动物成分,化学成分明确,无血清
 

产品说明书及文档

请在《产品说明书》中查找相关支持信息和使用说明,或浏览下方更多实验方案。

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
05990
Lot #
All
Language
English
Document Type
Technical Manual
Product Name
TeSR™-E8™
Catalog #
05990
Lot #
All
Language
English
Document Type
Safety Data Sheet 1
Catalog #
05990
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Catalog #
05990
Lot #
All
Language
English

应用领域

本产品专为以下研究领域设计,适用于工作流程中的高亮阶段。探索这些工作流程,了解更多我们为各研究领域提供的其他配套产品。

相关材料与文献

技术资料 (19)

文献 (53)

Comprehensive Cell Surface Protein Profiling Identifies Specific Markers of Human Naive and Primed Pluripotent States. Collier AJ et al. Cell stem cell 2017 MAR

Abstract

Human pluripotent stem cells (PSCs) exist in naive and primed states and provide important models to investigate the earliest stages of human development. Naive cells can be obtained through primed-to-naive resetting,but there are no reliable methods to prospectively isolate unmodified naive cells during this process. Here we report comprehensive profiling of cell surface proteins by flow cytometry in naive and primed human PSCs. Several naive-specific,but not primed-specific,proteins were also expressed by pluripotent cells in the human preimplantation embryo. The upregulation of naive-specific cell surface proteins during primed-to-naive resetting enabled the isolation and characterization of live naive cells and intermediate cell populations. This analysis revealed distinct transcriptional and X chromosome inactivation changes associated with the early and late stages of naive cell formation. Thus,identification of state-specific proteins provides a robust set of molecular markers to define the human PSC state and allows new insights into the molecular events leading to naive cell resetting.
Peripheral blood derived induced pluripotent stem cells (iPSCs) from a female with familial hypertrophic cardiomyopathy. S. B. Ross et al. Stem cell research 2017

Abstract

Induced pluripotent stem cells (iPSCs) were generated from peripheral blood mononuclear cells (PBMCs) obtained from a 62-year-old female with familial hypertrophic cardiomyopathy (HCM). PBMCs were reprogrammed to a pluripotent state following transfection with non-integrative episomal vectors carrying reprogramming factors OCT4,SOX2,LIN28,KLF4 and L-MYC. iPSCs were shown to express pluripotency markers,possess trilineage differentiation potential,carry rare variants identified in DNA isolated directly from the patient's whole blood,have a normal karyotype and no longer carry episomal vectors for reprogramming. This line is a useful resource for identifying unknown genetic causes of HCM.
Generation of non-transgenic iPS cells from human cord blood CD34+ cells under animal component-free conditions. A. Haase et al. Stem cell research 2017

Abstract

Recently,many hurdles and limitations for production of clinically applicable iPSC derivatives have been overcome. Transgene-free iPSCs can be efficiently derived from easily accessible cell sources such as blood. Here we describe the generation of transgene-free hiPS cells from cord blood derived CD34+ cells,reprogrammed using CytoTune™ Sendai reprogramming vectors. CD34+ cell isolation,cultivation,reprogramming and establishment of resulting hiPSC lines were performed under the exclusive usage of animal-derived component-free (ADCF) materials and components.

更多信息

更多信息
物种
配方 不含动物成分

法律声明:

本产品系基于WiCell™研究院(WiCell™ Research Institute)知识产权授权许可开发。本产品的出售目的仅限于基于不可转让、用途受限之许可下的研究用途(无论购买者为学术机构或营利性主体)。购买本产品并不被授予为商业用途(即,以获利为目的的任何行为,如将本产品用于制造用途、或转售本产品或使用本产品所制成的任何材料、或将本产品或使用本产品所制成的材料用于提供服务)或临床应用(即,将本产品或本产品所用材料应用于人体)而出售、使用或另行转让本产品的权利,或出于基础临床前研究应用(包括但不限于畸胎瘤试验)以外的目的,由营利性主体或与其合作,将使用本产品制造的任何材料植入动物体内的权利。
购买者若不同意前述条款和条件,应保持产品完好,将其退还出售方以获退款。

质量声明:

产品仅供研究使用,不用于针对人或动物的诊断或治疗。 欲获悉更多关于STEMCELL的质控信息,请访问 STEMCELL.CN/COMPLIANCE.

Copyright © 2026 by STEMCELL Technologies. All rights reserved.

在线联系